EMEA-002016-PIP04-20
Key facts
| Invented name |
Piqray
|
| Active substance |
Alpelisib
|
| Therapeutic area |
Oncology
|
| Decision number |
P/0122/2021
|
| PIP number |
EMEA-002016-PIP04-20
|
| Pharmaceutical form(s) |
All pharmaceutical forms
|
| Condition(s) / indication(s) |
|
| Route(s) of administration |
All routes of administration
|
| Contact for public enquiries |
Novartis Europharm Limited
E-mail: paediatric.enquiries@novartis.com |
| Decision type |
W: decision granting a waiver in all age groups for all conditions or indications
|